Catalog
Client
Currency:
+380 66 708 47 52
Our location:
Ternopil city
Phones:
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Wishlist
0
Compare
0
Contacts

Ibandronic acid-Vista film-coated tablets 50 mg blister No. 30

SKU: an-1046217
0
All about product
Description
Specification
Reviews 0
Questions0
new
Ibandronic acid-Vista film-coated tablets 50 mg blister No. 30
Ibandronic acid-Vista film-coated tablets 50 mg blister No. 30
Ibandronic acid-Vista film-coated tablets 50 mg blister No. 30
Ibandronic acid-Vista film-coated tablets 50 mg blister No. 30
In Stock
5 252.55 грн.
Buy this product in 1 click:
Active ingredient:Ibandronic acid
Adults:Can
ATC code:M MEDICINES AFFECTING THE MUSCULOSKOLE SYSTEM; M05 MEDICINES USED FOR THE TREATMENT OF BONE DISEASES; M05B MEDICINES AFFECTING BONE STRUCTURE AND MINERALIZATION; M05B A Bisphosphonates; M05B A06 Ibandronic acid
Country of manufacture:Spain
Diabetics:Can
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Ibandronic acid-Vista film-coated tablets 50 mg blister No. 30
5 252.55 грн.
Description

Ibandronic acid-Vista tablets are indicated for:

Prevention of skeletal injuries (pathological fractures, bone lesions requiring radiation therapy or surgical treatment) in patients with breast cancer and metastatic bone lesions.

Composition

Active ingredient: ibandronic acid;

1 film-coated tablet contains 50 mg of ibandronic acid in the form of ibandronate sodium monohydrate 56.25 mg;

Excipients: lactose monohydrate, microcrystalline cellulose, crospovidone (type A), colloidal silicon dioxide, sodium stearyl fumarate;

Film coating: (Opadry II white): polyvinyl alcohol, titanium dioxide (E 171), talc), macrogol 3350.

Contraindication

Hypersensitivity to ibandronic acid or any of the other ingredients of the drug. Hypocalcemia. Disease of the esophagus with delayed esophageal emptying, e.g. stricture, achalasia. Inability to remain upright (standing or sitting) for at least 60 minutes.

Method of application

The tablets should be swallowed whole with 1 glass of plain water (180-240 ml), while sitting or standing upright. Water with a high calcium concentration should not be used. If there are concerns about potentially high calcium levels in the water (hard water), it is recommended to use bottled water with a low mineral content.

Patients should not lie down for 60 minutes after taking the drug.

The drug should be taken with plain water only.

Patients should not chew or suck the tablet due to the possibility of ulceration of the oropharyngeal mucosa.

Application features

Pregnant women

Not applicable.

Children

Not applicable.

Drivers

Does not affect.

Overdose

There is no specific information on the treatment of overdose with the drug.

However, based on current knowledge of bisphosphonates, upper gastrointestinal adverse reactions (such as gastric upset, dyspepsia, oesophagitis, gastritis, ulcer) or hypocalcaemia may occur. Milk or antacids should be administered to bind the drug, and any adverse reactions should be treated symptomatically. Vomiting should not be induced due to the risk of oesophageal irritation. Patients should be kept in an upright position.

Side effects

On the part of the immune system: rarely - exacerbation of bronchial asthma; rarely - hypersensitivity reactions; very rarely - anaphylactic reactions / shock. On the part of the nervous system: often - headache, sometimes - dizziness. On the part of the organ of vision: rarely - eye inflammation. On the part of the gastrointestinal tract: often - esophagitis, gastritis, gastroesophageal reflux disease, dyspepsia, diarrhea, abdominal pain, nausea; sometimes - esophagitis, including esophageal ulcers or strictures and dysphasia, vomiting, flatulence; rarely - duodenitis. On the part of the skin and subcutaneous tissue: often - rash.

Interaction

The oral bioavailability of ibandronic acid is reduced in the presence of food. In particular, calcium-containing foods, including milk, and other polyvalent cations (aluminum, magnesium, iron) may impair absorption of the drug, which is consistent with the results obtained in animal studies. Therefore, the drug should be taken after an overnight fast (at least 6 hours).

Storage conditions

Keep out of reach of children.

Store at a temperature not exceeding 25 °C.

Shelf life - 3 years.

Specifications
Characteristics
Active ingredient
Ibandronic acid
Adults
Can
ATC code
M MEDICINES AFFECTING THE MUSCULOSKOLE SYSTEM; M05 MEDICINES USED FOR THE TREATMENT OF BONE DISEASES; M05B MEDICINES AFFECTING BONE STRUCTURE AND MINERALIZATION; M05B A Bisphosphonates; M05B A06 Ibandronic acid
Country of manufacture
Spain
Diabetics
Can
Dosage
50 мг
Drivers
Can
For allergies
With caution
For children
It is impossible.
Form
Film-coated tablets
Method of application
Inside, solid
Nursing
It is impossible.
Pregnant
It is impossible.
Primary packaging
blister
Producer
Mistral Capital Management
Quantity per package
30 pcs
Trade name
Ibandronic acid
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

5 252.55 грн.